StockNews.com Begins Coverage on Galectin Therapeutics (NASDAQ:GALT)
StockNews.com started coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research note issued to investors on Monday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright restated a buy rating and set a $11.00 target price on shares of Galectin Therapeutics in a report on Tuesday, August […]
More Stories
Greenup Street Wealth Management LLC Sells 4,626 Shares of Tesla, Inc. (NASDAQ:TSLA)
Greenup Street Wealth Management LLC trimmed its position in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) by 19.5% in...
Compass Wealth Management LLC Sells 68 Shares of Costco Wholesale Co. (NASDAQ:COST)
Compass Wealth Management LLC cut its holdings in Costco Wholesale Co. (NASDAQ:COST – Free Report) by 2.4% during the 3rd...
BCS Wealth Management Increases Holdings in AT&T Inc. (NYSE:T)
BCS Wealth Management lifted its stake in AT&T Inc. (NYSE:T – Free Report) by 1.7% in the 3rd quarter, according...
iShares MSCI EAFE ETF (NYSEARCA:EFA) Stock Position Lifted by Sax Wealth Advisors LLC
Sax Wealth Advisors LLC boosted its position in shares of iShares MSCI EAFE ETF (NYSEARCA:EFA – Free Report) by 22.9%...
Trifecta Capital Advisors LLC Raises Stock Holdings in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Trifecta Capital Advisors LLC lifted its stake in shares of iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) by...
Marshall Financial Group LLC Takes $1.01 Million Position in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH)
Marshall Financial Group LLC acquired a new stake in iShares Core S&P Mid-Cap ETF (NYSEARCA:IJH – Free Report) in the...